Procyon Stock Analysis
| PCYN Stock | USD 0.12 0.00 0.00% |
Procyon holds a debt-to-equity ratio of 0.26. With a high degree of financial leverage come high-interest payments, which usually reduce Procyon's Earnings Per Share (EPS).
Asset vs Debt
Equity vs Debt
Procyon's liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. Procyon's cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps Procyon Pink Sheet's retail investors understand whether an upcoming fall or rise in the market will negatively affect Procyon's stakeholders.
For most companies, including Procyon, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for Procyon, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, Procyon's management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Given that Procyon's debt-to-equity ratio measures a Company's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which Procyon is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of Procyon to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, Procyon is said to be less leveraged. If creditors hold a majority of Procyon's assets, the Company is said to be highly leveraged.
Procyon is overvalued with Real Value of 0.1 and Hype Value of 0.12. The main objective of Procyon pink sheet analysis is to determine its intrinsic value, which is an estimate of what Procyon is worth, separate from its market price. There are two main types of Procyon's stock analysis: fundamental analysis and technical analysis.
The Procyon pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
Procyon |
Procyon Pink Sheet Analysis Notes
About 65.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.77. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Procyon had not issued any dividends in recent years. Procyon Corporation, together with its subsidiaries, develops and markets proprietary medical products for use in the treatment of pressure ulcers, stasis ulcers, wounds, dermatitis, inflammation, and other skin problems in the United States. The company was incorporated in 1987 and is based in Oldsmar, Florida. Procyon Corp operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 19 people.The quote for Procyon is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Procyon contact Justice Anderson at 727 447 2998 or learn more at https://procyoncorp.com.Procyon Investment Alerts
| Procyon generated a negative expected return over the last 90 days | |
| Procyon has some characteristics of a very speculative penny stock | |
| The company reported the previous year's revenue of 4.84 M. Net Loss for the year was (209.79 K) with profit before overhead, payroll, taxes, and interest of 3.49 M. | |
| Procyon currently holds about 1.04 M in cash with (229.46 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.13, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 65.0% of the company outstanding shares are owned by corporate insiders |
Procyon Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 2 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Procyon's market, we take the total number of its shares issued and multiply it by Procyon's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Procyon Profitablity
The company has Profit Margin (PM) of (0.05) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.07) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.07.Technical Drivers
Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Procyon, as well as the relationship between them.Procyon Price Movement Analysis
Study |
The minimum time period for execution of this function requires larger time horizon. Please increase the time horizon for this function. The output start index for this execution was zero with a total number of output elements of zero. The Instantaneous Trendline is a moving-average-like indicator which is formed by removing the Dominant Cycle from Procyon price series.
Procyon Outstanding Bonds
Procyon issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Procyon uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Procyon bonds can be classified according to their maturity, which is the date when Procyon has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Procyon Debt to Cash Allocation
Procyon currently holds 694.3 K in liabilities with Debt to Equity (D/E) ratio of 0.26, which may suggest the company is not taking enough advantage from borrowing. Procyon has a current ratio of 3.94, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Procyon until it has trouble settling it off, either with new capital or with free cash flow. So, Procyon's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Procyon sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Procyon to invest in growth at high rates of return. When we think about Procyon's use of debt, we should always consider it together with cash and equity.Procyon Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Procyon's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Procyon, which in turn will lower the firm's financial flexibility.Procyon Corporate Bonds Issued
About Procyon Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Procyon prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Procyon shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Procyon. By using and applying Procyon Pink Sheet analysis, traders can create a robust methodology for identifying Procyon entry and exit points for their positions.
Procyon Corporation, together with its subsidiaries, develops and markets proprietary medical products for use in the treatment of pressure ulcers, stasis ulcers, wounds, dermatitis, inflammation, and other skin problems in the United States. The company was incorporated in 1987 and is based in Oldsmar, Florida. Procyon Corp operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 19 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Procyon to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Odds Of Bankruptcy Now
Odds Of BankruptcyGet analysis of equity chance of financial distress in the next 2 years |
| All Next | Launch Module |
Other Information on Investing in Procyon Pink Sheet
Procyon financial ratios help investors to determine whether Procyon Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Procyon with respect to the benefits of owning Procyon security.